Connect with us

Hi, what are you looking for?

Health Care

Medicare won’t cover controversial Alzheimer’s drug — unless patients are in a clinical trial

FDA approved the drug on an accelerated pathway, which requires a fourth clinical trial to demonstrate that the drug actually slows cognitive decline.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


You May Also Like

TOP news

Paul Sancya/AP On June 2, Delta will become the first US airline to pay its flight attendants for boarding time. Previously, flight attendants were...

Opinion

Adeline van Houtte is the Economist Intelligence Unit’s lead analyst on Russia. It looks like Russia is at it again, after the unusual movement...

World

The EU should play an active role in the upcoming U.S.-Russia talks over security concerns around Ukraine, the bloc’s top diplomat told German media...

TOP news

US Navy aircraft carrier USS Carl Vinson leads other US Navy ships during an exercise with the Indian navy in 2012. US Navy Photo...